A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2009
11/26/2009	US20090291888 Modulators of tnf receptor associated factor (traf), their preparation and use
11/26/2009	US20090291128 Transdermal delivery of cannabinoids
11/26/2009	US20090291079 Phosphatidylinositol 3 (PI3); Mammalian Target of Rapamycin, mTOR; triazine compounds substituted with either morpholino or tetrahydropyranyl rings on the triazine ring; anticancer agents, atherosclerosis, bone disorders, psoriasis, BPH, pancreatitis, kidney disease
11/26/2009	US20090291050 Particulate materials
11/26/2009	CA2761971A1 Rice bran extracts for inflammation and methods of use thereof
11/26/2009	CA2725001A1 Dihydroindolone derivatives
11/26/2009	CA2724818A1 New optically pure compounds for improved therapeutic efficiency
11/26/2009	CA2724812A1 Co-crystals of duloxetine and cox-inhibitors for the treatment of pain
11/26/2009	CA2724788A1 Hepatoprotectant acetaminophen mutual prodrugs
11/26/2009	CA2724592A1 Agent for maintenance of induced remission
11/26/2009	CA2724584A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009	CA2724508A1 Phenyl and benzodioxinyl substituted indazoles derivatives
11/26/2009	CA2724357A1 Novel thiophenediamine derivative having urea structure
11/25/2009	EP2123752A2 Novel nucleic acid
11/25/2009	EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses
11/25/2009	EP2123669A1 Copolymers for suppression of autoimmune diseases, and methods of use
11/25/2009	EP2123665A2 Inhibitors of interleukin-1Beta converting enzyme
11/25/2009	EP2123663A1 Method for production of sugar oxazoline derivative
11/25/2009	EP2123651A1 Condensed pyridine compound
11/25/2009	EP2123649A1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
11/25/2009	EP2123647A1 2-(amino-substituted)-4-phenyl pyrimidines useful for treating inflammatory diseases
11/25/2009	EP2123626A1 Co-crystals of duloxetine and co-crystal formers for the treatment of pain
11/25/2009	EP2123297A1 Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient
11/25/2009	EP2123295A1 Therapeutic agent for interstitial pneumonia
11/25/2009	EP2123272A1 Adam inhibitor
11/25/2009	EP2121727A1 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan
11/25/2009	EP2121585A1 Novel aminoguanidines as melanocortin receptor ligands.
11/25/2009	EP2120950A1 Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome
11/25/2009	EP2120920A2 Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
11/25/2009	EP2120919A1 New combination for use in the treatment of inflammatory disorders
11/25/2009	EP2120567A1 Prodrugs of substituted 1,3-dioxanes and their uses
11/25/2009	EP1663398B1 Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline reuptake inhibitors
11/25/2009	EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors
11/25/2009	EP1322299B1 Composition for the transdermal delivery of fentanyl
11/25/2009	EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009	EP1113797B1 Use of duloxetine for the treatment of fibromyalgia
11/25/2009	CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/25/2009	CN101585860A 4',5,6-trimethoxy scutellarin as well as preparation method and pharmaceutical composition thereof
11/25/2009	CN101585859A Novel scutellarin derivative as well as preparation method and pharmaceutical composition thereof
11/25/2009	CN101585841A Guaianolide sesquiterpene dimers, preparation method thereof and use thereof
11/25/2009	CN101585823A New immunosuppressive agent extracted from Honghuoma and extraction method and use thereof
11/25/2009	CN101585760A Method for preparing flurbiprofen
11/25/2009	CN101585757A Method for preparing curcumin, demethoxycurcumin and bisdemethoxycurcumin
11/25/2009	CN101584855A Pharmaceutical preparation and preparation method thereof
11/25/2009	CN101584848A Chinese medicament for treating qi stagnation, food accumulation and cold bind type bellyache diseases
11/25/2009	CN101584827A Traditional Chinese medicine for treating cold in children
11/25/2009	CN101584784A Traditional Chinese medicine for pediatric defervescence
11/25/2009	CN101584755A External liquid medicine for treating rheumatism bone pains and traumatic injuries and preparation method thereof
11/25/2009	CN101584752A Extraction and purification process for total flavonoids in Anchusa italica Retiz
11/25/2009	CN101584689A Compound eardrops containing antipyrine and lidocaine the and preparation method thereof
11/25/2009	CN101584458A Health-protection tea for relieving inflammation and resolving phlegm for middle-aged people
11/25/2009	CN101584368A Health tea for clearing heat and promoting blood circulation of middle-aged people
11/25/2009	CN100562518C Novel arylethene-sulfonamides compounds
11/25/2009	CN100562330C The Chinese traditional medicinal powder for hemostasia, acesodyne, myogenic, sore, healing and its preparation method
11/25/2009	CN100562328C Chinese medicinal composition for treating cold
11/25/2009	CN100562319C 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
11/24/2009	US7622612 Tricyclic derivatives and their use
11/24/2009	US7622487 Piperidine derivative, process for producing the same, and use
11/24/2009	US7622484 Such as asthma or chronic obstructive pulmonary disease; a corticoid such as mometasone furoate and 5-(1-hydroxy-2-((5,6-diethylindan-2-yl)amino)ethyl)8-hydroxy-1,2-dihydroquinolin-2-one or salt such as maleate
11/24/2009	US7622464 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists
11/24/2009	US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009	US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009	CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009	CA2445678C Paroxetine controlled release compositions
11/24/2009	CA2423836C Composition for the delivery of fentanyl
11/24/2009	CA2423384C New cross-linked derivatives of hyaluronic acid
11/24/2009	CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009	CA2413337C Bioadhesive compositions and methods of preparation and use
11/24/2009	CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/24/2009	CA2403831C Coating and binding agent for pharmaceutical formulations having improved storage stability
11/24/2009	CA2385882C Tyrosine derivatives
11/24/2009	CA2279427C Use of low dose photodynamic therapy for reducing the effects of inflammation
11/19/2009	WO2009140642A2 Tricyclic antagonists of prostaglandin d2 receptors
11/19/2009	WO2009140287A1 Salinosporamide derivatives as proteasome inhibitors
11/19/2009	WO2009140059A2 Narcotic emulsion formulations for treatment of surgical pain
11/19/2009	WO2009139916A1 Tricyclic triazole compounds that modulate hsp90 activity
11/19/2009	WO2009139880A1 Thioxoisoindoline compounds and compositions and methods of using the same
11/19/2009	WO2009139373A1 Amide compound
11/19/2009	WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009	WO2009138758A2 Bis-aryl compounds for use as medicaments
11/19/2009	WO2009138416A1 Oxime carbamoyl derivatives as modulators of fatty acid amides hydrolase
11/19/2009	WO2009138376A1 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
11/19/2009	WO2009138340A1 Inhibitors of jnk
11/19/2009	WO2009046220A3 Lipopeptides for delivery of nucleic acids
11/19/2009	US20090286986 Isoindole-imide compounds, compositions, and uses thereof
11/19/2009	US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few
11/19/2009	US20090286858 Assays for modulators of asparaginyl hydroxylase
11/19/2009	US20090286840 Polo-like kinase inhibitors such as 5-(5-Amino-2H-pyrazol-3-yl)-3-[1-(2-chloro-phenyl)-ethoxy]-thiophene-2-carboxylic acid amide, useful for treating or preventing autoimmune, inflammatory, proliferative or hyperproliferative disease, a neurodegenerative disease, or an immunologically-mediated disease
11/19/2009	US20090286833 Substituted Cyclohexylmethyl Compounds
11/19/2009	US20090286832 Narcotic emulsion formulations for treatment of surgical pain
11/19/2009	US20090286813 Thioxanthine Derivatives and Their Use as Inhibitors of MPO
11/19/2009	US20090286798 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
11/19/2009	US20090286792 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
11/19/2009	US20090286786 Compounds having a 4-pyridylalkylthio group as a substituent
11/19/2009	US20090286775 Bicyclic Derivatives as P38 Kinase Inhibitors
11/19/2009	US20090286767 Substituted quinolin-4-ylamine analogues
11/19/2009	US20090286742 polypeptides comprising amino acid sequences corresponding to, similar to or homologous to part of the amino acid sequence of neural thread proteins, used for treating unwanted cellular proliferations such as benign prostatatic hyperplasia, cancer, unwanted facial hair, warts and fatty tissues
11/19/2009	US20090286740 Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009	US20090286739 Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009	US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)

1 ... 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 ... 1272